Microbial communities

  • Article|

    It is demonstrated that the brain circuitry involved in regulating the motivation for physical activity is not strictly central nervous system autonomous but is shaped by peripheral influences that originate in the intestinal microbial community.

    • Lenka Dohnalová
    • ,Patrick Lundgren
    • &Christoph A. Thaiss
  • Article|

    Enterococci enhance the fitness and pathogenesis ofClostridioides difficilein the gut by altering the amino acid composition and providing signals that increase its virulence towards the host.

    • Alexander B. Smith
    • ,Matthew L. Jenior
    • &Joseph P. Zackular
  • Article|

    Dietary inulin fibre alters the composition and metabolism of gut microbiota, resulting in elevated levels of bile acids that subsequently trigger mucosal type 2 inflammation characterized by eosinophilia, with clinical implications for allergy and anti-helminth defence.

    • Mohammad Arifuzzaman
    • ,Tae Hyung Won
    • &David Artis
  • Article|

    A computational system termed MetaWIBELE (workflow to identify novel bioactive elements in the microbiome) is used to identify microbial gene products that are potentially bioactive and have a functional role in the pathogenesis of inflammatory bowel disease.

    • Yancong Zhang
    • ,Amrisha Bhosle
    • &埃里克·a·Franzosa
  • Article|

    A study in which gut microbiomes of 8,208 individuals from 2,756 families were characterized and correlated to 241 host and environmental factors defines microbiome patterns shared across diverse diseases and shows that the microbiome is shaped largely by environment and cohabitation.

    • R. Gacesa
    • ,A. Kurilshikov
    • &R. K. Weersma
  • Article|

    A survey of species-level genes from 13,174 publicly available metagenomes shows that most species-level genes are specific to a single habitat, encode a small number of protein families and are under low positive (adaptive) pressure.

    • Luis Pedro Coelho
    • ,Renato Alves
    • &Peer Bork
  • Article|

    Bacteria in the human gut and oral microbiome encode enzymes that selectively phosphorylate the antidiabetic drug acarbose—an inhibitor of both human and bacterial α-glucosidases—resulting in its inactivation and limiting the drug's effects on the ability of the host to metabolize complex carbohydrates.

    • Jared Balaich
    • ,Michael Estrella
    • &Mohamed S. Donia
  • Article|

    This study systematically profiles the activity of several classes of antibiotics on gut commensal bacteria and identifies drugs that mitigate their collateral damage on commensal bacteria without compromising their efficacy against pathogens.

    • Lisa Maier
    • ,Camille V. Goemans
    • &Athanasios Typas
  • Article|

    An analysis of the interactions between 15 drugs and 25 gut bacterial strains shows that bioaccumulation of drugs within bacterial cells is another mechanism through which gut microorganisms can alter drug availability and efficacy.

    • Martina Klünemann
    • ,Sergej Andrejev
    • &Kiran R. Patil
  • Article|

    The microbiota of centenarians (aged 100 years and older) comprise gut microorganisms that are capable of generating unique secondary bile acids, including isoallolithocholic acid, a bile acid with potent antimicrobial effects against Gram-positive—but not Gram-negative—multidrug-resistant pathogens.

    • Yuko Sato
    • ,Koji Atarashi
    • &Kenya Honda
  • Article|

    Acetate—a major gut microbial metabolite—increases the production of IgA in the colon, alters the capacity of the IgA pool to bind to specific microorganisms and alters the localization of these bacteria within the colon.

    • Tadashi Takeuchi
    • ,Eiji Miyauchi
    • &Hiroshi Ohno
  • Article|

    Fibre snacks that target distinct features of the microbiomes of donors with obesity transplanted into gnotobiotic mice also lead to fibre-specific changes in the microbiome and physiology when used in controlled-diet human studies.

    • Omar Delannoy-Bruno
    • ,Chandani Desai
    • &Jeffrey I. Gordon
  • Article
    |Open Access

    Ancient microbiomes from palaeofaeces are more similar to non-industrialized than industrialized human gut microbiomes regardless of geography, but 39% of their de novo reconstructed genomes represent previously undescribed microbial species.

    • Marsha C. Wibowo
    • ,Zhen Yang
    • &Aleksandar D. Kostic
  • Article|

    Absolute microbial abundances delineate longitudinal dynamics of bacteria, fungi and archaea in the infant gut microbiome, uncovering drivers of microbiome development masked by relative abundances and revealing notable parallels to macroscopic ecosystem assemblies.

    • Chitong Rao
    • ,Katharine Z. Coyte
    • &赛斯Rakoff-Nahoum
  • Article|

    High-phylogenetic-resolution microbiome mapping by fluorescence in situ hybridization (HiPR-FISH) enables the spatial mapping of hundreds of species of microorganisms and shows how microbial networks in the mouse gut are affected by antibiotic treatment.

    • Hao Shi
    • ,Qiaojuan Shi
    • &Iwijn De Vlaminck
  • Article|

    Influence of the gut microbiome on the human immune system is revealed by systems analysis of vast clinical data from decades of electronic health records paired with massive longitudinal microbiome sequencing.

    • Jonas Schluter
    • ,Jonathan U. Peled
    • &Joao B. Xavier
  • Article|

    Experiments using an ecologically realistic 185-member bacterial synthetic community in the root system ofArabidopsisreveal thatVariovoraxbacteria can influence plant hormone levels to reverse the inhibitory effect of the community on root growth.

    • Omri M. Finkel
    • ,Isai Salas-González
    • &Jeffery L. Dangl
  • Review Article|

    This Review describes the interplay between host genetics, host immunity and the gut microbiome in the modulation of colorectal cancer, and discusses the role of specific bacterial species and metabolites alongside technological advances that will facilitate more in-depth investigation of the microbiome in disease.

    • Alina Janney
    • ,Fiona Powrie
    • &Elizabeth H. Mann
  • Article|

    A combination of gnotobiotic mouse models, transcriptomics, circuit tracing and chemogenetic manipulations identifies neuronal circuits that integrate microbial signals in the gut with regulation of the sympathetic nervous system.

    • Paul A. Muller
    • ,Marc Schneeberger
    • &Daniel Mucida
  • Article|

    Mutations in genes involved in immune signalling and vesicle trafficking cause defects in the leaf microbiome ofArabidopsis thalianathat result in damage to leaf tissues, suggesting mechanisms by which terrestrial plants control the level and diversity of endophytic phyllosphere microbiota.

    • Tao Chen
    • ,Kinya Nomura
    • &Sheng Yang He
  • Article|

    Analyses of microbial communities that live 10–750 m below the seafloor at Atlantis Bank, Indian Ocean, provide insights into how these microorganisms survive by coupling energy sources to organic and inorganic carbon resources.

    • Jiangtao Li
    • ,Paraskevi Mara
    • &Virginia P. Edgcomb
  • Article|

    Microbial nucleic acids are detected in samples of tissues and blood from more than 10,000 patients with cancer, and machine learning is used to show that these can be used to discriminate between and among different types of cancer, suggesting a new microbiome-based diagnostic approach.

    • Gregory D. Poore
    • ,Evguenia Kopylova
    • &Rob Knight
  • Article|

    Metabolomics data from germ-free and specific-pathogen-free mice reveal effects of the microbiome on host chemistry, identifying conjugations of bile acids that are also enriched in patients with inflammatory bowel disease or cystic fibrosis.

    • Robert A. Quinn
    • ,Alexey V. Melnik
    • &Pieter C. Dorrestein
  • Article
    |Open Access

    Genomic analyses of major clades of huge phages sampled from across Earth’s ecosystems show that they have diverse genetic inventories, including a variety of CRISPR–Cas systems and translation-relevant genes.

    • Basem Al-Shayeb
    • ,Rohan Sachdeva
    • &Jillian F. Banfield
  • Article|

    Neonatal mice are protected against infection with the enteric pathogen enterotoxigenicEscherichia coliby maternally derived natural antibodies as well as by maternal commensal microbiota that induce antibodies that recognize antigens expressed by Enterobacteriaceae.

    • Wen Zheng
    • ,Wenjing Zhao
    • &Dennis L. Kasper
  • Article|

    Both dietary and microbial factors influence the composition of the gut bile acid pool, which in turn modulates the frequencies and functionalities of RORγ-expressing colonic FOXP3+regulatory T cells, contributing to protection from inflammatory colitis.

    • Xinyang Song
    • ,Ximei Sun
    • &Dennis L. Kasper
  • Article|

    一个interbacterial国防战略,涉及俱乐部ters of immunity genes against toxins released by the type VI secretion system of the same or different species, is widespread among Bacteroides species, and transfer of these gene clusters confers resistance to toxins in vitro and in the mammalian gut.

    • Benjamin D. Ross
    • ,Adrian J. Verster
    • &Joseph D. Mougous
  • Article|

    The human placenta does not have a microbiota, suggesting that bacterial infection of the placenta is not a common cause of adverse pregnancy outcome, but group B Streptococcus is found in approximately 5% of placental samples.

    • Marcus C. de Goffau
    • ,Susanne Lager
    • &Gordon C. S. Smith
  • Perspective
    |Open Access

    Over ten years, the Human Microbiome Project has provided resources for studying the microbiome and its relationship to disease; this Perspective summarizes the key achievements and findings of the project and its relationship to the broader field.

    • Lita M. Proctor
    • ,Heather H. Creasy
    • &Curtis Huttenhower
  • Article
    |Open Access

    The Inflammatory Bowel Disease Multi’omics Database includes longitudinal data encompassing a multitude of analyses of stool, blood and biopsies of more than 100 individuals, and provides a comprehensive description of host and microbial activities in inflammatory bowel diseases.

    • Jason Lloyd-Price
    • ,Cesar Arze
    • &Curtis Huttenhower
  • Article|

    The authors systematically characterize structural variation in the genomes of gut microbiota and show that they are associated with bacterial fitness and with host risk factors, and that examining genes coded in these regions facilitates investigation of mechanisms that may underlie these associations.

    • David Zeevi
    • ,Tal Korem
    • &Eran Segal
  • Article
    |Open Access

    The known species repertoire of the collective human gut microbiota is substantially expanded with the discovery of 1,952 uncultured bacterial species that greatly improve classification of understudied African and South American samples.

    • Alexandre Almeida
    • ,Alex L. Mitchell
    • &Robert D. Finn
  • Article|

    从治疗的11个菌株组成的一个联盟thy human gut microbiota can strongly induce interferon-γ-producing CD8 T cells in the intestine, and enhance both resistance to bacterial infection and the therapeutic efficacy of immune checkpoint inhibitors.

    • Takeshi Tanoue
    • ,Satoru Morita
    • &Kenya Honda
  • Letter
    |Open Access

    An analysis of more than 10,000 metagenomes from the TEDDY study provides a detailed functional profile of the gut microbiome in relation to islet autoimmunity, and supports the protective effects of short-chain fatty acids in early-onset type 1 diabetes.

    • Tommi Vatanen
    • ,埃里克·a·Franzosa
    • &Ramnik J. Xavier